Hologic Financial Statements (HOLX)
|
|
|
|
Report date
|
|
|
06.02.2025 |
02.05.2025 |
31.07.2025 |
18.11.2025 |
29.01.2026 |
|
29.01.2026 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
1 022 |
1 005 |
1 024 |
1 050 |
1 048 |
|
4 126 |
|
Operating Income, bln rub |
|
|
229.8 |
-7.00 |
254.6 |
237.0 |
237.0 |
|
721.6 |
|
EBITDA, bln rub |
? |
|
352.0 |
76.8 |
334.0 |
319.5 |
283.6 |
|
1 014 |
|
Net profit, bln rub |
? |
|
201.0 |
-17.4 |
194.9 |
187.3 |
179.1 |
|
543.9 |
|
|
OCF, bln rub |
? |
|
189.3 |
169.4 |
343.3 |
355.1 |
229.9 |
|
1 098 |
|
CAPEX, bln rub |
? |
|
47.0 |
40.2 |
12.8 |
30.4 |
14.7 |
|
98.1 |
|
FCF, bln rub |
? |
|
142.3 |
129.2 |
330.5 |
324.7 |
215.2 |
|
999.6 |
|
Dividend payout, bln rub
|
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
|
Ordinary share dividend yield, %
|
|
|
|
|
|
|
|
|
0.00% |
|
Dividend payout ratio, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
|
OPEX, bln rub |
|
|
350.7 |
384.3 |
322.0 |
402.1 |
349.4 |
|
1 458 |
|
Cost of production, bln rub |
|
|
441.3 |
628.0 |
447.2 |
410.4 |
461.4 |
|
1 947 |
|
R&D, bln rub |
|
|
60.3 |
61.5 |
61.4 |
65.1 |
60.5 |
|
248.5 |
|
Interest expenses, bln rub |
|
|
30.5 |
29.1 |
28.9 |
9.60 |
27.6 |
|
95.2 |
|
|
Assets, bln rub |
|
|
8 729 |
8 545 |
8 806 |
9 015 |
9 181 |
|
9 181 |
|
Net Assets, bln rub |
? |
|
4 773 |
4 619 |
4 843 |
5 048 |
5 245 |
|
5 245 |
|
Debt, bln rub |
|
|
2 540 |
2 531 |
2 523 |
2 627 |
2 520 |
|
2 520 |
|
Cash, bln rub |
|
|
1 973 |
1 621 |
1 879 |
2 203 |
2 365 |
|
2 365 |
|
Net debt, bln rub |
|
|
567.7 |
910.0 |
643.4 |
424.1 |
155.6 |
|
155.6 |
|
|
Ordinary share price, rub |
|
|
|
|
|
|
|
|
76.0 |
|
Number of ordinary shares, mln |
|
|
230.3 |
225.8 |
224.3 |
225.7 |
224.4 |
|
224.4 |
|
|
Market cap, bln rub |
|
|
0 |
0 |
0 |
0 |
0 |
|
17 057 |
|
EV, bln rub |
? |
|
568 |
910 |
643 |
424 |
156 |
|
17 213 |
|
Book value, bln rub |
|
|
557 |
321 |
556 |
818 |
1 053 |
|
1 053 |
|
|
EPS, rub |
? |
|
0.87 |
-0.08 |
0.87 |
0.83 |
0.80 |
|
2.42 |
|
FCF/share, rub |
|
|
0.62 |
0.57 |
1.47 |
1.44 |
0.96 |
|
4.45 |
|
BV/share, rub |
|
|
2.42 |
1.42 |
2.48 |
3.63 |
4.69 |
|
4.69 |
|
|
EBITDA margin, % |
? |
|
34.4% |
7.64% |
32.6% |
30.4% |
27.1% |
|
24.6% |
|
Net margin, % |
? |
|
19.7% |
-1.73% |
19.0% |
17.8% |
17.1% |
|
13.2% |
|
FCF yield, % |
? |
|
|
|
|
|
|
|
5.86% |
|
ROE, % |
? |
|
15.6% |
12.1% |
11.5% |
11.2% |
10.4% |
|
10.4% |
|
ROA, % |
? |
|
8.52% |
6.51% |
6.33% |
6.28% |
5.92% |
|
5.92% |
|
|
P/E |
? |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
31.4 |
|
P/FCF |
|
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
17.1 |
|
P/S |
? |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
4.13 |
|
P/BV |
? |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
16.2 |
|
EV/EBITDA |
? |
|
0.42 |
0.83 |
0.59 |
0.39 |
0.15 |
|
17.0 |
|
Debt/EBITDA |
|
|
0.42 |
0.83 |
0.59 |
0.39 |
0.15 |
|
0.15 |
|
|
R&D/CAPEX, % |
|
|
128.3% |
153.0% |
479.7% |
214.1% |
411.6% |
|
253.3% |
|
|
CAPEX/Revenue, % |
|
|
4.60% |
4.00% |
1.25% |
2.90% |
1.40% |
|
2.38% |
|
| Hologic shareholders |
